Mendis, S., Anand, S., Karasinska, J. M., Dasari, A., Unger, J. M., Gothwal, A., . . . Loree, J. M. (2020). Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies. Oncologist.
Chicago Style CitationMendis, Shehara, et al. "Sex Representation in Clinical Trials Associated With FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies." Oncologist 2020.
Cita MLAMendis, Shehara, et al. "Sex Representation in Clinical Trials Associated With FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies." Oncologist 2020.
Atenció: Aquestes cites poden no estar 100% correctes.